GFVIX
Price
$16.05
Change
+$0.11 (+0.69%)
Updated
Sep 4 closing price
Net Assets
57.82M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GFVIX vs VVIAX

Header iconGFVIX vs VVIAX Comparison
Open Charts GFVIX vs VVIAXBanner chart's image
Goldman Sachs Focused Value I
Price$16.05
Change+$0.11 (+0.69%)
VolumeN/A
Net Assets57.82M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GFVIX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFVIX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVIX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GFVIX (57.8M). VVIAX pays higher dividends than GFVIX: VVIAX (2.10) vs GFVIX (1.19). GFVIX was incepted earlier than VVIAX: GFVIX (10 years) vs VVIAX (25 years). GFVIX (1.43) is less costly to investors than VVIAX (0.05). GFVIX is a more actively managed with annual turnover of: 85.00 vs. VVIAX (9.00). GFVIX has a lower initial minimum investment than VVIAX: GFVIX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GFVIX (1.17). VVIAX return over 5 years is better than : 70.16 vs. GFVIX (48.24).
GFVIXVVIAXGFVIX / VVIAX
Total Expense Ratio0.760.051,520%
Annual Report Gross Expense Ratio1.430.052,860%
Fund Existence10 years25 years-
Gain YTD3.3837.85043%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets57.8M203B0%
Annual Yield % from dividends1.192.1056%
Returns for 1 year1.177.7415%
Returns for 3 years26.9936.6174%
Returns for 5 years48.2470.1669%
Returns for 10 years87.85131.6167%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity